ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SLS SELLAS Life Sciences Group Inc

1.261
-0.069 (-5.19%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
SELLAS Life Sciences Group Inc NASDAQ:SLS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.069 -5.19% 1.261 1.28 1.32 1.3385 1.25 1.33 711,112 00:59:40

EQUITY ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important May 5, 2014 Class Action Deadline -- GALE

22/04/2014 10:06pm

GlobeNewswire Inc.


SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more SELLAS Life Sciences Charts.

The Rosen Law Firm, P.A. today reminds all purchasers of the common stock of Galena Biopharma, Inc. (Nasdaq:GALE) between November 6, 2013 and February 14, 2014, inclusive of the important May 5, 2014 lead plaintiff deadline in the class action filed by the firm.

To join the Galena class action, go to the website at http://rosenlegal.com or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that Galena was engaged in a misleading stock promotion. When this adverse information entered the market, the price of Galena stock fell, damaging investors. As a result, the SEC is now investigating Galena.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2014. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe concentrating its practice in securities class actions.

CONTACT: Laurence Rosen, Esq.
         Phillip Kim, Esq.
         Kevin Chan, Esq.
         The Rosen Law Firm P.A.
         275 Madison Avenue 34th Floor
         New York, New York 10016
         Tel: (212) 686-1060
         Toll Free: (866) 767-3653
         Fax: (212) 202-3827
         lrosen@rosenlegal.com
         pkim@rosenlegal.com
         kchan@rosenlegal.com
         www.rosenlegal.com

1 Year SELLAS Life Sciences Chart

1 Year SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

1 Month SELLAS Life Sciences Chart

Your Recent History

Delayed Upgrade Clock